These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Preliminary Proxy Statement
|
|
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
þ
|
|
Definitive Proxy Statement
|
|
o
|
|
Definitive Additional Materials
|
|
o
|
|
Soliciting Material Pursuant to §240.14a-12
|
|
þ
|
|
No fee required.
|
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
o
|
|
Fee paid previously with preliminary materials.
|
|
|
|
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
|
|
|
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
|
||
|
|
To Be Held May 21, 2015
|
|
|
1.
|
To re-elect two Class III Supervisory Directors to serve until our annual meeting in
2018
and until their successors shall have been duly elected and qualified;
|
|
2.
|
To ratify the appointment of PricewaterhouseCoopers LLP ("PricewaterhouseCoopers" or "PwC") as our Company's independent registered public accountants for the year ending December 31,
2015
;
|
|
3.
|
To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the CD&A, and the compensation of Core Laboratories N.V.'s named executive officers as disclosed pursuant to the Security and Exchange Commission's compensation disclosure rules, including the compensation tables;
|
|
4.
|
To confirm and adopt our Dutch Statutory Annual Accounts in the English language for the fiscal year ended December 31,
2014
;
|
|
5.
|
To approve and resolve the cancellation of our repurchased shares held at 12:01 a.m. CEST on
May 21, 2015
;
|
|
6.
|
To approve and resolve the extension of the existing authority to repurchase up to
10%
of our issued share capital from time to time for an 18-month period, until
November 21, 2016
, and such repurchased shares may be used for any legal purpose;
|
|
7.
|
To approve and resolve the extension of the authority to issue shares and/or to grant rights (including options to purchase) with respect to our common and preference shares up to a maximum of
10%
of outstanding shares per annum until
November 21, 2016
;
|
|
8.
|
To approve and resolve the extension of the authority to limit or exclude the preemptive rights of the holders of our common shares and/or preference shares up to a maximum of
10%
of outstanding shares per annum until
November 21, 2016
;
|
|
9.
|
To approve the appointment of the international KPMG accounting firm, including its U.S. and Dutch affiliates, (collectively, "KPMG") as our Company's independent registered public accountants for the year ending December 31,
2016
in advance of the rotation of our Dutch independent registered public accountants for that year as required by new Dutch regulations; and
|
|
10.
|
To transact such other business as may properly come before the annual meeting or any adjournment thereof.
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
||
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
PROXY STATEMENT
|
|
|
1.
|
To re-elect two Class III Supervisory Directors to serve until our annual meeting in
2018
and until their successors shall have been duly elected and qualified;
|
|
2.
|
To ratify the appointment of PricewaterhouseCoopers as our Company's independent registered public accountants for the year ending December 31,
2015
;
|
|
3.
|
To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the CD&A, and the compensation of Core Laboratories N.V.'s named executive officers as disclosed pursuant to the SEC's compensation disclosure rules, including the compensation tables;
|
|
4.
|
To confirm and adopt our Dutch Statutory Annual Accounts in the English language for the fiscal year ended December 31,
2014
;
|
|
5.
|
To approve and resolve the cancellation of our repurchased shares held at 12:01 a.m. CEST on
May 21, 2015
;
|
|
6.
|
To approve and resolve the extension of the existing authority to repurchase up to
10%
of our issued share capital from time to time for an 18-month period, until
November 21, 2016
, and such repurchased shares may be used for any legal purpose;
|
|
7.
|
To approve and resolve the extension of the authority to issue shares and/or to grant rights (including options to purchase) with respect to our common and preference shares up to a maximum of
10%
of outstanding shares per annum until
November 21, 2016
;
|
|
8.
|
To approve and resolve the extension of the authority to limit or exclude the preemptive rights of the holders of our common shares and/or preference shares up to a maximum of
10%
of outstanding shares per annum until
November 21, 2016
;
|
|
9.
|
To approve the appointment of KPMG as our Company's independent registered public accountants for the year ending December 31,
2016
in advance of the rotation of our Dutch independent registered public accountants for that year as required by new Dutch regulations; and
|
|
10.
|
To transact such other business as may properly come before the annual meeting or any adjournment thereof.
|
|
•
|
each person known by us to own beneficially 5% or more of our outstanding common shares;
|
|
•
|
each Supervisory Director;
|
|
•
|
each nominee for election as Supervisory Director;
|
|
•
|
each of our named executive officers; and
|
|
•
|
all Supervisory Directors and executive officers as a group (all eight Supervisory Directors own shares of Company stock).
|
|
Name of Beneficial Owner (1)
|
|
Number of Common Shares Beneficially Owned
|
|
Percentage of Common Shares Outstanding (2)
|
|
|
Clearbridge Investments, LLC (3)
|
|
4,668,050
|
|
|
11%
|
|
The Vanguard Group (4)
|
|
2,971,828
|
|
|
7%
|
|
EARNEST Partners, LLC (5)
|
|
2,675,223
|
|
|
6%
|
|
Capital World Investors (6)
|
|
2,459,760
|
|
|
6%
|
|
Wedgewood Partners Inc (7)
|
|
2,220,875
|
|
|
5%
|
|
David M. Demshur
|
|
303,133
|
|
|
*
|
|
Richard L. Bergmark
|
|
129,737
|
|
|
*
|
|
Monty L. Davis
|
|
99,266
|
|
|
*
|
|
D. John Ogren
|
|
39,288
|
|
|
*
|
|
Michael C. Kearney
|
|
11,826
|
|
|
*
|
|
Jan Willem Sodderland
|
|
1,305
|
|
|
*
|
|
Charles L. Dunlap
|
|
800
|
|
|
*
|
|
Margaret van Kempen
|
|
350
|
|
|
*
|
|
Lucia van Geuns
|
|
95
|
|
|
*
|
|
All Supervisory Directors and executive officers as a group
|
585,800
|
|
|
1%
|
|
|
(1)
|
Unless otherwise indicated, each person has sole voting power and investment power with respect to the common shares listed.
|
|
(2)
|
Based on
43,122,059
common shares outstanding as of
March 13, 2015
.
|
|
(3)
|
Based upon an Amendment No.
9
to Schedule 13G/A filed with the SEC on
2/10/2015
,
Clearbridge Investments, LLC
is deemed to be the beneficial owner of
4,668,050
shares. Clearbridge Investments' current address is 620 8th Avenue, New York, NY 10018.
|
|
(4)
|
Based upon an Amendment No.
2
to Schedule 13G/A filed with the SEC on
2/9/2015
,
The Vanguard Group
is deemed to be the beneficial owner of
2,971,828
shares. Vanguard's current address is 100 Vanguard Blvd., Malvern, PA 19355.
|
|
(5)
|
Based upon an Amendment No.
3
to Schedule 13G filed with the SEC on
2/11/2015
,
EARNEST Partners, LLC
is deemed to be the beneficial owner of
2,675,223
shares. EARNEST Partners' current address is 1180 Peachtree Street NE, Suite 2300, Atlanta, GA 30309.
|
|
(6)
|
Based upon an Amendment No.
8
to Schedule 13G/A filed with the SEC on
2/6/2015
,
Capital World Investors
is deemed to be the beneficial owner of
2,459,760
shares as a result of Capital Research and Management Company acting as investment adviser to various investment companies registered under Section 8 of the Investment Company Act of 1940.
Capital World Investors
' current address is 333 South Hope Street, 55th Floor, Los Angeles, CA 90071.
|
|
(7)
|
Based upon Schedule 13F filed with the SEC on
2/17/2015
,
Wedgewood Partners Inc
is deemed to be the beneficial owner of
2,220,875
shares. Wedgewood's current address is 9909 Clayton Road, Suite 103, St Louis, MO 63124.
|
|
|
|
Number of Common Shares to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
|
|
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
|
|
Number of Common Shares Remaining Available for Future Issuance Under Equity Compensation Plans
|
|||
|
Equity compensation plans approved by our shareholders
|
|
|
|
|
|
|
|||
|
2014 Long-Term Incentive Plan
|
|
450,323
|
|
|
—
|
|
|
1,500,029
|
|
|
2014 Director Plan
|
|
18,998
|
|
|
—
|
|
|
564,965
|
|
|
Equity compensation plans not approved by our shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
469,321
|
|
|
—
|
|
|
2,064,994
|
|
|
Nominees for Class III Supervisory Directors (Term to Expire
2018
)
|
||
|
Richard L. Bergmark, 61
Executive Vice President and Chief Financial Officer
Supervisory Director since initial public offering in 1995
|
|
Mr. Bergmark joined Western Atlas International, Inc. as Treasurer in 1987. From 1987 to 1994, our Company was operated as a division of Western Atlas. In 1991, Mr. Bergmark became the Area Manager for Finance and Administration for Europe, Africa and the Middle East operations of Western Geophysical, a division of Western Atlas. From our separation with Western Atlas in 1994 until 1999, he served as our Chief Financial Officer and Treasurer and in 1999 he was appointed Executive Vice President. He has substantial knowledge of the industry based upon his over 25 years with the Company and its predecessors and has extensive knowledge about the history of the Company, both of which are important for planning and management purposes. Furthermore, his understanding of the financial matters relating to the Company and our industry are of crucial importance to the Company. Mr. Bergmark, along with our Chief Executive Officer, has developed important contacts with others in the industry and has an excellent relationship with our shareholders.
|
|
|
|
|
|
Margaret Ann van Kempen, 62
Supervisory Director since 2012
Member of Nominating, Governance and Corporate Responsibility Committee and Compensation Committee
|
|
Ms. van Kempen has been the owner and managing partner of Van Kempen Public Relations & Public Affairs since 1997. She has extensive experience in strategic corporate communications and investor relations, with a focus on reputation and risk management. She has provided litigation PR and communications advice on a wide variety of issues in high profile cases in and outside The Netherlands. Her clients cover a range of sectors including telecommunications, energy, information technology, professional services and fashion. From 1988 to 1995 she was Director European Affairs of Financial Times Television. Before that she worked in government and semi-government organizations including the Ministry of Economic Affairs. Ms. van Kempen's background in corporate communications and knowledge of strategic investor relations, including her knowledge of such matters in Europe, allow her to provide unique insight to the Company particularly in light of our dual listing on the Euronext Amsterdam Stock Exchange.
|
|
Continuing Class I Supervisory Directors (Term to Expire 2017)
|
||
|
David M. Demshur, 59
Chief Executive Officer and Supervisory Director
since initial public offering in 1995
Chairman of Supervisory
Board since May 2001 |
|
Since joining our Company in 1979, Mr. Demshur has held various operating positions, including Manager of Geological Sciences from 1983 to 1987, Vice President of Europe, Africa and the Middle East from 1989 to 1991, Senior Vice President of Petroleum Services from 1991 to 1994 and Chief Executive Officer and President from 1994 to the present time. Mr. Demshur's extensive background with the Company and the diversity of experiences gained while in these leadership roles positions him to be an effective leader of our Company. Mr. Demshur is a member of the Society of Petroleum Engineers, the American Association of Petroleum Geologists, the Petroleum Exploration Society of Great Britain and the Society of Core Analysts Section of the Society of Professional Well Loggers Association.
|
|
|
|
|
|
Michael C. Kearney, 66
Supervisory Director since 2004
Chairman of Audit Committee
|
|
In January 2015, Mr. Kearney was elected to the Board of Directors of Fairmount Santrol, a company specializing in high-performance sand and sand-based products used by oil and gas exploration and production companies, and was also appointed to serve on its Audit Committee. Since November 2013, Mr. Kearney has also served on the Supervisory Board of Frank's International N.V., a Dutch company specializing in supplying engineered tubular services for the oil and gas industry, and as chairman of its Audit Committee. Mr. Kearney formerly served as President and Chief Executive Officer of DeepFlex Inc. from September 2009 until June 2013 and had served as the Chief Financial Officer of DeepFlex Inc. from January 2008 until September 2009. Previously, he served as Executive Vice President and Chief Financial Officer of Tesco Corporation, a Canadian based oil service company from October 2004 to January 2007. From 1998 until 2004, Mr. Kearney served as the Chief Financial Officer and Vice President - Administration of Hydril Company, a manufacturer of products for petroleum drilling and production. Mr. Kearney brings to the Company significant accounting expertise as a result of his work experience and educational training. His executive level experience as Chief Financial Officer at publicly traded companies and direct knowledge and experience of operating and maintaining internal controls over financial reporting benefits the Company given Mr. Kearney's former positions as a certifying officer. Mr. Kearney has a Master of Science degree in Accountancy and a BBA degree in Finance.
|
|
|
|
|
|
Jan Willem Sodderland, 73
Supervisory Director since 2011 Member of Compensation Committee
|
|
Mr. Sodderland serves on the board of European subsidiaries of a number of international companies. From 1974 until 2006, Mr. Sodderland was an attorney and partner of NautaDutilh and was stationed in Rotterdam, Brussels and Amsterdam. In his practice, Mr. Sodderland has built up considerable experience in assisting and advising companies in complicated takeovers, mergers and joint ventures. Mr. Sodderland has long had a close relationship with Japan and China and has published a number of articles about investment possibilities in Asia. He is also the past Chairman of the Pacific Rim Advisory Council, an association of some thirty independent law firms in various parts of the world. His legal practice and service on boards has given him broad, diversified exposure to best practices for corporate governance. Prior to his election to the Supervisory Board in 2011, Mr. Sodderland served as a non-employee managing director of Core Laboratories International B.V. ("CLIBV"), which is the managing director of the Company, and as a non-employee director of other Dutch affiliates of the Company.
|
|
Continuing Class II Supervisory Directors (Term To Expire 2016)
|
||
|
D. John Ogren, 71
Supervisory Director since 2000
Chairman of Compensation Committee
Member of Audit Committee
|
|
Mr. Ogren served as the President of Production Operators, Inc. from 1994 until 1999. Production Operators was listed on the Nasdaq Stock Market prior to its acquisition by Camco International in 1997 and Schlumberger's acquisition of Camco International in 1998. From 1989 until 1991, Mr. Ogren served as Senior Vice President of Conoco Inc. and from 1992 until 1994, as Senior Vice President of E.I. duPont. Mr. Ogren served as a director of the John Wood Group PLC until May 2011 and as Chairman of Deepflex Inc. until August 2011. Previously, he served as non-executive Chairman of WellDynamics, a Halliburton/Shell joint venture. He is a member of the Society of Petroleum Engineers. The combination of Mr. Ogren's experiences within the oilfield service sector in addition to his senior level work experience within an oil and gas operating company provide valuable insight for the Company. Having served in senior operating and executive management positions as well as in the role of Chairman of other companies during his career, he has the background to deal with the many facets of planning as well as issues related to compensation that are handled in his role as Chairman of the Compensation Committee.
|
|
|
|
|
|
Charles L. Dunlap, 71
Supervisory Director since 2013
Chairman of Nominating, Governance and Corporate Responsibility Committee
Member of Audit Committee and Compensation Committee
|
|
Mr. Dunlap formerly served as Chief Executive Officer and President of TransMontaigne, a terminaling and transportation company, and Chief Executive Officer of TransMontaigne Partners L.P., a publicly-traded master limited partnership, both based in Denver, Colorado until the end of 2014. Mr. Dunlap previously served as Chief Executive Officer and President of Pasadena Refining System, Inc., based in Houston, Texas from January 2005 to December 2008. From 2000 to 2004, Mr. Dunlap served as one of the founding partners of Strategic Advisors, L.L.C., a management consulting firm based in Baltimore, Maryland. Prior to that time, Mr. Dunlap served in various senior management and executive positions at various oil and gas companies including Crown Central Petroleum Corporation, Pacific Resources Inc., ARCO Petroleum Products Company and Clark Oil & Refining Corporation. Mr. Dunlap is a graduate of Rockhurst University, holds a Juris Doctor degree from Saint Louis University Law School and is a graduate of the Harvard Business School Advanced Management Program. Mr. Dunlap's extensive management experience in the oil and gas sector as well as his diverse educational background allow him to provide valuable insight on management and strategic issues.
|
|
|
|
|
|
Lucia van Geuns, 59
Supervisory Director since 2013
Member of Nominating, Governance and Corporate Responsibility Committee
|
|
I
n January 2015, Ms. van Geuns became a senior consultant in petroleum geosciences with The Netherlands Organization for Applied Scientific Research (“TNO”). Her research at TNO will focus on the impact of production optimization technology, international energy markets and energy transition. Prior to this, she was a Senior Fellow at the Clingendael International Energy Programme from 2003 to 2014, where she focused on the geopolitics and macro-economics of international energy markets and energy transition. In September 2013, she became the President of the Royal Geological and Mining Society of the Netherlands (KNGMG). She started her career in 1980 as a petroleum geologist at the Shell Research Laboratories for Royal Dutch Shell plc. in Rijswijk, after which she served for Brunei Shell Petroleum from 1983 to 1986. In her 22 years with Royal Dutch Shell she held many different technical and management positions, including manager of Geological Services in Rijswijk from 1989 to 1993 and leader of various exploration and production projects during the 1990s, including the large Camisea gas/liquid project in Peru and field development planning in the Niger delta. She has a strong background in geoscience, petroleum engineering and economics & planning. She is a frequent speaker on energy market issues for various public and private stakeholders. Ms. van Geuns holds an MSc in Earth Sciences from the University of Leiden and is a member of various professional associations. Ms. van Geuns' background in geology, her extensive technical experience in international petroleum projects and her knowledge of petroleum economics provide a set of skills complementary to the other members of the Supervisory Board.
|
|
Name
|
|
Fee Earned or Paid in Cash ($)
|
|
Stock Awards ($) (1)(2)
|
|
Total
($)
|
||
|
Charles L. Dunlap
|
|
80,500
|
|
|
148,433
|
|
|
228,933
|
|
Michael C. Kearney
|
|
89,100
|
|
|
148,433
|
|
|
237,533
|
|
D. John Ogren
|
|
104,650
|
|
|
148,433
|
|
|
253,083
|
|
Jan Willem Sodderland
|
|
56,700
|
|
|
148,433
|
|
|
205,133
|
|
Lucia van Geuns
|
|
56,700
|
|
|
148,433
|
|
|
205,133
|
|
Margaret Ann van Kempen
|
|
62,250
|
|
|
148,433
|
|
|
210,683
|
|
(1)
|
The amounts included in the "Stock Awards" column include the aggregate grant date fair value of the equity-based awards granted during
2014
and have been computed in accordance with FASB ASC Topic 718, formerly FAS 123(R).
|
|
(2)
|
Each of our non-executive Supervisory Directors who served any portion of
2014
still had the following aggregate number of stock awards, for their
2012
RSAPs (as defined below),
2013
RSAPs and
2014
RSAPs, outstanding as of December 31,
2014
: Mr.
Dunlap
,
1,844
; Mr.
Kearney
,
2,985
; Mr.
Ogren
,
2,985
; Mr.
Sodderland
,
2,985
; Ms.
van Geuns
,
1,844
; and Ms.
van Kempen
,
2,985
. None of our non-executive Supervisory Directors had any option awards outstanding as of December 31,
2014
.
|
|
•
|
a base annual retainer, payable semiannually in arrears, in the amount of
$45,000
;
|
|
•
|
an additional annual retainer for the following positions:
|
|
◦
|
for our Lead Director, an additional
$15,000
;
|
|
◦
|
for our Audit Committee chairman, an additional
$25,000
;
|
|
◦
|
for our Compensation Committee chairman, an additional
$20,000
;
|
|
◦
|
for our Nominating, Governance and Corporate Responsibility Committee chairman, an additional
$9,000
;
|
|
•
|
$2,000
per meeting of the Supervisory Board at which the individual is present in person;
|
|
•
|
$1,850
per meeting for each committee meeting at which the individual is present in person; and
|
|
•
|
reimbursement for all out-of-pocket expenses incurred in attending any Supervisory Board or committee meeting.
|
|
•
|
Other services provided to us by Frost;
|
|
•
|
Fees paid by us as a percentage of Frost’s total revenue;
|
|
•
|
Policies or procedures maintained by Frost that are designed to prevent a conflict of interest;
|
|
•
|
Any business or personal relationships between the individual consultants involved in the engagement and members of the Compensation Committee;
|
|
•
|
Any stock of the Company owned by the individual consultants involved in the engagement; and
|
|
•
|
Any business or personal relationships between our executive officers and Frost or the individual consultants involved in the engagement.
|
|
•
|
recommending candidates to the Supervisory Board for election as Supervisory Directors;
|
|
•
|
recommending candidates to the Supervisory Board for appointment to the Supervisory Board's committees;
|
|
•
|
reviewing and overseeing compliance with the Company's corporate governance and social responsibility policies; and
|
|
•
|
leading the Supervisory Board in its annual review of the performance of the Supervisory Board, its committees and management.
|
|
•
|
information about the goods or services proposed to be or being provided by or to the related party or the nature of the transactions;
|
|
•
|
the nature of the transactions and the costs to be incurred by the Company or payments to the Company;
|
|
•
|
an analysis of the costs and benefits associated with the transaction and a comparison of comparable or alternative goods or services that are available to the Company from unrelated parties;
|
|
•
|
the business advantage the Company would gain by engaging in the transaction; and
|
|
•
|
an analysis of the significance of the transaction to the Company and to the related party.
|
|
•
|
a member of the compensation committee (or other Supervisory Board committee performing equivalent functions or, in the absence of any such committee, the entire Supervisory Board of Directors) of another entity, one of whose named executive officers served on our Compensation Committee;
|
|
•
|
a member of the compensation committee (or other Supervisory Board committee performing equivalent functions or, in the absence of any such committee, the entire Supervisory Board of Directors) of another entity, one of whose named executive officers served as one of our Supervisory Directors; or
|
|
•
|
a director of another entity, one of whose named executive officers served on our Compensation Committee or the board of directors of one of our subsidiaries.
|
|
•
|
All non-executive Supervisory Board members are deemed independent under the NYSE rules;
|
|
•
|
All members of the Audit Committee, Compensation Committee and NGCR Committee are non-employees and are independent;
|
|
•
|
The charters of the Supervisory Board committees clearly establish their respective roles and responsibilities;
|
|
•
|
The Board of Supervisory Directors has adopted corporate governance policies; and
|
|
•
|
Core Laboratories has a code of ethics and corporate responsibility that applies to all employees and Supervisory Board members.
|
|
•
|
Our Code of Ethics and Corporate Responsibility.
|
|
•
|
Full-time Compliance Officer.
|
|
•
|
Access to a telephone and web portal helpline monitored by the Compliance Officer and available 24 hours a day and seven days a week for reporting any suspected wrongdoing or for obtaining answers on ethics, fraud, regulatory compliance other questions.
|
|
•
|
Annual training and certification of compliance with the Code of Ethics and Corporate Responsibility.
|
|
•
|
Strictly enforcing our policy against whistleblower retaliation.
|
|
•
|
Posters at each office with the Code of Ethics and Corporate Responsibility
and Helpline Access Information.
|
|
•
|
Zero tolerance on unethical conduct, including termination for any such occurrence, as warranted.
|
|
•
|
Completion of a "Reportable Transaction and Conflicts of Interest" questionnaire on a bi-annual basis.
|
|
•
|
Employee review of the Law Department's Anti-Corruption and Export Controls presentations and certifications of compliance with those policies on an annual basis.
|
|
•
|
Background investigations and reference checks: These investigations, which include verifying a candidate's education, employment history, criminal record, and professional references, are performed for all individuals being considered for employment.
|
|
•
|
Delegation of Responsibility: Management has developed policies and procedures to ensure that employees to whom significant responsibility has been delegated have the necessary skills and experience.
|
|
•
|
Effective HR-related practices, such as training and regular performance evaluations.
|
|
•
|
Management and development: The Company has a Human Resources department that promotes the management and development of effective human resources programs
|
|
•
|
All issues are sorted and categorized (legal, ethics or other) by the Ethics & Compliance Officer, who reports to the General Counsel. All calls of a legal nature are handled by the General Counsel.
|
|
•
|
These reporting procedures have been made available to all employees of the Company.
|
|
•
|
Treating others with courtesy and respect in all work relationships.
|
|
•
|
Eliminating harassing conduct, including unwanted touching, or comments or behavior that is sexual, sexist, racially or religiously based, or otherwise discriminatory.
|
|
•
|
Reporting harassment to the Human Resources Department, the Corporate Compliance Officer or the Law Department so that each concern is investigated promptly and resolved appropriately.
|
|
•
|
Take a Behavior Based Approach to Health and Safety.
|
|
•
|
Engineer Better Solutions and Improvements on Our Existing Products and Services.
|
|
•
|
Empower Employees to Make Smart Decisions.
|
|
•
|
Training and education.
|
|
•
|
Zero Incident culture.
|
|
•
|
Systematic identification of risks, addressing them and following up to closure.
|
|
•
|
Comply with all applicable local, state, and federal environmental laws and regulations.
|
|
•
|
Be responsible for protective environmental management.
|
|
•
|
Focus on research and development of products that minimize impact on the environment.
|
|
•
|
Educate all employees on their roles and responsibilities for protecting the environment.
|
|
•
|
Increasing base salaries of named executive officers by 4.0% on average for
2015
, but postponing those increases until the energy industry improves and until our other employees are eligible to receive a merit increase;
|
|
•
|
Awarding zero annual cash incentive compensation for
2014
performance for the named executive officers due to the failure of the Company to achieve the minimum EPS target; and
|
|
•
|
Awarding named executive officers only performance share award program (PSAP) equity for
2014
and
2015
.
|
|
•
|
Provide a competitive compensation program that enables us to retain key executives and Supervisory Board members;
|
|
•
|
Ensure a strong relationship between our performance results and those of our segments and the total compensation received by an individual;
|
|
•
|
Balance annual and longer term performance objectives;
|
|
•
|
Encourage executives to acquire and retain meaningful levels of common shares; and
|
|
•
|
Work closely with the Chief Executive Officer to ensure that the compensation program supports our objectives and culture.
|
|
Atwood Oceanics, Inc.
|
|
Dril-Quip, Inc.
|
|
Oceaneering International, Inc.
|
|
Cameron International Corp.
|
|
FMC Technologies Inc.
|
|
Oil States International, Inc.
|
|
CARBO Ceramics, Inc.
|
|
Helix Energy Solutions Group, Inc.
|
|
RPC, Inc.
|
|
Dresser-Rand Group, Inc.
|
|
Nabors Industries Ltd
|
|
Superior Energy Services, Inc.
|
|
•
|
the individual's experience and background;
|
|
•
|
the individual's performance during the prior year;
|
|
•
|
the benchmark salary data;
|
|
•
|
the general movement of salaries in the marketplace; and
|
|
•
|
our financial and operating results.
|
|
Name
|
|
2015 ($)
|
|
2014 ($)
|
|
David Demshur
|
|
989,000
|
|
951,000
|
|
Richard Bergmark
|
|
528,000
|
|
508,600
|
|
Monty Davis
|
|
528,000
|
|
508,600
|
|
•
|
share our success with employees;
|
|
•
|
provide a financial incentive to focus on specific performance targets;
|
|
•
|
reward employees based on individual and team performance;
|
|
•
|
promote a sense of shared accomplishment among employees; and
|
|
•
|
encourage employees to continually improve our financial and operating performance and thereby create shareholder value.
|
|
|
|
Award Percentages
|
||
|
Name
|
Title
|
Target
|
|
Maximum
|
|
David M. Demshur
|
President and Chief Executive Officer
|
110%
|
-
|
220%
|
|
Richard L. Bergmark
|
Executive Vice President and Chief Financial Officer
|
75%
|
-
|
150%
|
|
Monty L. Davis
|
Senior Vice President and Chief Operating Officer
|
75%
|
-
|
150%
|
|
Name of Executive
|
Amount of Award Subject to Top Decile Vesting Requirement for 80% of the Award (in Shares)
|
Amount of Award Subject to Top Performer Vesting Requirement for 20% of the Award (in Shares)
|
Total Award of 100% (in Shares)
|
|
David Demshur
|
35,268
|
8,817
|
44,085
|
|
Richard Bergmark
|
14,148
|
3,537
|
17,685
|
|
Monty Davis
|
14,148
|
3,537
|
17,685
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Stock Awards
($) (1)
|
|
Non-Equity Incentive Plan Compensation
($)
|
|
Change in Post-employment Benefit Value and Nonqualified Deferred Compensation Earnings
($) (2)
|
|
All Other Compensation
($) (3) (4)
|
|
Total
($)
|
|
David M. Demshur
|
|
2014
|
|
951,000
|
|
3,453,450
|
|
—
|
|
78,000
|
|
17,008
|
|
4,499,458
|
|
President and Chief Executive Officer
|
|
2013
|
|
910,000
|
|
3,757,727
|
|
1,820,000
|
|
(438,000)
|
|
16,622
|
|
6,066,349
|
|
|
2012
|
|
875,000
|
|
3,533,945
|
|
1,750,000
|
|
313,000
|
|
15,229
|
|
6,487,174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard L. Bergmark
|
|
2014
|
|
508,600
|
|
1,385,293
|
|
—
|
|
80,000
|
|
17,030
|
|
1,990,923
|
|
Executive Vice President, and Chief Financial Officer
|
|
2013
|
|
486,720
|
|
1,507,438
|
|
730,080
|
|
(416,000)
|
|
16,660
|
|
2,324,898
|
|
|
2012
|
|
468,000
|
|
1,499,363
|
|
702,000
|
|
303,000
|
|
15,263
|
|
2,987,626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Monty L. Davis
|
|
2014
|
|
508,600
|
|
1,385,293
|
|
—
|
|
46,000
|
|
16,650
|
|
1,956,543
|
|
Senior Vice President and Chief Operating Officer
|
|
2013
|
|
486,720
|
|
1,507,438
|
|
730,080
|
|
(265,000)
|
|
16,645
|
|
2,475,883
|
|
|
2012
|
|
468,000
|
|
1,499,363
|
|
702,000
|
|
188,000
|
|
15,249
|
|
2,872,612
|
|
|
(1)
|
The amounts included in the "Stock Awards" column include the aggregate grant date fair value of the equity-based awards granted during
2012
,
2013
and
2014
, and have been computed in accordance with FASB ASC Topic 718, formerly FAS 123(R). Assumptions used in the calculation of these amounts are included in Note 13 to our audited financial statements for the fiscal years ended December 31,
2012
,
2013
and
2014
and are included in our annual reports on Form 10-K. See "Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table" for a description of the material features of these awards.
|
|
(2)
|
The changes in post-employment benefit values for
2012
,
2013
and
2014
were primarily the result of changes in the underlying actuarial assumptions. Specifically, the interest rate is based on a federal rate that changes annually and the mortality tables are pursuant to Section 417 of the Code which is required for valuing payouts from qualified plans. These changes were not the result of additional contributions or benefits accruing to the named executive officers.
|
|
(3)
|
All named executive officers received perquisites in excess of $10,000 in fiscal
2012
,
2013
and
2014
due to Company 401(k) discretionary contributions and an increase in premium with the Company-Owned Life Insurance.
|
|
(4)
|
The amounts shown reflect discretionary contributions made by the Company. Amounts previously reported for 2012 have been reduced to reflect a corrective adjustment made in 2013.
|
|
Name
|
|
Year
|
|
Core 401(k) Contributions
($) (1)
|
|
Core 401(k) Discretionary Contributions
($) (2) (3)
|
|
Company-Owned Life Insurance($) (4)
|
|
Total
($)
|
|
David M. Demshur
|
|
2014
|
|
10,400
|
|
6,436
|
|
172
|
|
17,008
|
|
|
|
2013
|
|
10,200
|
|
6,236
|
|
186
|
|
16,622
|
|
|
|
2012
|
|
10,000
|
|
5,041
|
|
188
|
|
15,229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard L. Bergmark
|
|
2014
|
|
10,400
|
|
6,436
|
|
194
|
|
17,030
|
|
|
|
2013
|
|
10,200
|
|
6,236
|
|
224
|
|
16,660
|
|
|
|
2012
|
|
10,000
|
|
5,041
|
|
222
|
|
15,263
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Monty L. Davis
|
|
2014
|
|
10,032
|
|
6,436
|
|
182
|
|
16,650
|
|
|
|
2013
|
|
10,200
|
|
6,236
|
|
209
|
|
16,645
|
|
|
|
2012
|
|
10,000
|
|
5,041
|
|
208
|
|
15,249
|
|
(1)
|
The amounts shown reflect Company matching contributions.
|
|
(2)
|
The amounts shown reflect the additional discretionary contributions made by the Company.
|
|
(3)
|
The amounts shown reflect discretionary contributions made by the Company. Amounts previously reported for 2012 have been reduced to reflect a corrective adjustment made in 2013.
|
|
(4)
|
The amounts shown reflect premiums we pay for life insurance coverage for our named executive officers, which insurance payments will be used to assist us with providing death benefits under the deferred compensation plan.
|
|
|
|
|
|
|
|
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards
|
|
All Other Stock Awards: Number of Shares of Stock or Units
(#)
|
|
Grant Date Fair Value of Stock and Option Awards
($)
|
|||||||||
|
Name
|
|
Grant Date
|
|
Approval Date
(1)
|
|
Threshold
($)
|
|
Target
($)
|
|
Maximum
($)
|
|
|
|||||||
|
David M. Demshur
|
|
|
|
|
|
—
|
|
|
951,000
|
|
|
1,902,000
|
|
|
|
|
|
||
|
|
|
2/10/2014
|
|
1/27/2014
|
|
|
|
|
|
|
|
19,946
|
|
|
3,453,450
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Richard L. Bergmark
|
|
|
|
|
|
—
|
|
|
381,450
|
|
|
762,900
|
|
|
|
|
|
||
|
|
|
2/10/2014
|
|
1/27/2014
|
|
|
|
|
|
|
|
8,001
|
|
|
1,385,293
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Monty L. Davis
|
|
|
|
|
|
—
|
|
|
381,450
|
|
|
762,900
|
|
|
|
|
|
||
|
|
|
2/10/2014
|
|
1/27/2014
|
|
|
|
|
|
|
|
8,001
|
|
|
1,385,293
|
|
|||
|
Name
|
|
Number of Shares or Units of Stock That Have Not Vested
(#)
|
|
Market Value of Shares or Units of Stock That Have Not Vested
($)
|
|||
|
David M. Demshur
|
|
|
49,164
|
|
(1)
|
|
5,916,396
|
|
Richard L. Bergmark
|
|
|
19,722
|
|
(1)
|
|
2,373,345
|
|
Monty L. Davis
|
|
|
19,722
|
|
(1)
|
|
2,373,345
|
|
(1)
|
Includes performance restricted shares remaining unvested which were granted to the named executive officer in
2013
and
2014
. See "Narrative Disclosure to Summary Compensation Table and Grants of Plan Based Awards Table -- Performance Restricted Share Award Program".
|
|
|
|
Stock Awards
|
||
|
Name
|
|
Number of Shares
Acquired on Vesting
(#)
|
|
Value Realized on Vesting
($)
|
|
David M. Demshur
|
|
29,835
|
|
3,590,344
|
|
Richard L. Bergmark
|
|
12,587
|
|
1,514,720
|
|
Monty L. Davis
|
|
12,587
|
|
1,514,720
|
|
Name
|
|
Plan Name
|
|
Number of Years
Credited Service
(#)
|
|
Present Value of
Accumulated Benefit
($)
|
|
Payments During 2014
($)
|
|
David M. Demshur
|
|
Group SERP
|
|
N/A
|
|
4,204,000
|
|
—
|
|
Richard L. Bergmark
|
|
Group SERP
|
|
N/A
|
|
4,280,000
|
|
—
|
|
Monty L. Davis
|
|
Individual SERP
|
|
25
|
|
2,538,000
|
|
—
|
|
|
|
Executive Contributions in 2014
|
|
Registrant Contributions in 2014
|
|
Aggregate Earnings (Losses) in 2014
|
|
Aggregate Withdrawals/(Distributions)
|
|
Aggregate Balance at December 31, 2014
|
|||||
|
Name
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|||||
|
David M. Demshur
|
|
110,013
|
|
|
31,232
|
|
|
613,451
|
|
|
—
|
|
|
6,417,202
|
|
|
Richard L. Bergmark
(1)
|
|
12,324
|
|
|
24,187
|
|
|
49,928
|
|
|
—
|
|
|
851,941
|
|
|
Monty L. Davis
|
|
782,060
|
|
|
39,257
|
|
|
41,169
|
|
|
—
|
|
|
2,396,871
|
|
|
(1) Registrant Contributions in 2014 includes an adjustment of $11,863 for 2013
|
|||||||||||||||
|
a.
|
the payment of a lump-sum amount equal to the sum of:
|
|
◦
|
200% of his base salary as in effect immediately prior to the termination; and
|
|
◦
|
two times 45% of the maximum annual incentive bonus he could have earned pursuant to his employment agreement;
|
|
b.
|
provision of a benefits package for the executive and his spouse and dependent children consisting of medical, hospital, dental, disability and life insurance benefits at least as favorable as those benefits provided to the executive
|
|
c.
|
the provision of outplacement services at a cost not to exceed 100% of the executive's annual base salary as in effect immediately prior to the termination; and
|
|
d.
|
the full and immediate vesting and exercisability of all of his outstanding stock options, which options shall remain exercisable for the greater of (1) three months following such termination, or (2) the period provided in the plan or plans pursuant to which such stock options were granted.
|
|
•
|
a discount rate of
4.00%
;
|
|
•
|
mortality table under section 417(e)(3)(A)(ii)(I), the 2014 Applicable Mortality Table for Lump Sums under the Pension Protection Act of 2006 (PPA);
|
|
•
|
a current medical trend of
5.70%
per annum, decreasing in accordance with a schedule over time to
5.40%
in
2016
and
5.50%
in
2019
;
|
|
•
|
that medical benefits are to be coordinated with Medicare such that premiums will be reduced by 70% for ages 65 and older; and
|
|
•
|
that the health plan is self-funded and will continue to be so in the future.
|
|
•
|
the basic life insurance benefit was valued as a whole life premium at discount rate of
3.50%
;
|
|
•
|
mortality table under section 417(e)(3)(A)(ii)(I), the
2014
Applicable Mortality Table for Lump Sums under PPA;
|
|
•
|
the accidental death and disability coverage was valued as
10.80%
of the value of basic life insurance benefit, per the current premium ratio and this benefit was assumed to continue beyond age 65; and
|
|
•
|
the long-term disability premium was escalated to
4.00%
until age 65, reflecting the age-related incidence of disability as well as increased administrative costs; no value is attributed to the benefit beyond age 65, as long-term disability coverage is rarely available once employment ends.
|
|
•
|
his base salary as in effect immediately prior to his termination of employment; and
|
|
•
|
the greater of (A) 45% of the maximum annual incentive bonus he could have earned pursuant to his employment contract for the year in which his employment terminates or (B) the highest annual bonus he received in the three fiscal years ending prior to the fiscal year in which occurred the change in control.
|
|
David M. Demshur
|
|
Voluntary Termination on 12/31/2014
($)
|
|
Early Retirement on 12/31/2014($)
|
|
Involuntary Not For Cause Termination on 12/31/2014($)
|
|
For Cause Termination on 12/31/2014($)
|
|
Termination related to Change-in-Control on 12/31/2014
($)
|
|
Disability on 12/31/2014
($)
|
|
Death on 12/31/2014
($)
|
|||||||
|
Compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Severance
|
|
1,902,000
|
|
|
1,902,000
|
|
|
1,902,000
|
|
|
—
|
|
|
2,853,000
|
|
|
—
|
|
|
—
|
|
|
Short-term Incentive
|
|
1,711,800
|
|
|
1,711,800
|
|
|
1,711,800
|
|
|
—
|
|
|
5,460,000
|
|
|
—
|
|
|
—
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Unvested and Accelerated
Equity Award Programs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,916,396
|
|
|
5,916,396
|
|
|
5,916,396
|
|
|
Benefits & Perquisites:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Health and Welfare Benefits
|
|
576,008
|
|
|
576,008
|
|
|
576,008
|
|
|
—
|
|
|
576,008
|
|
|
576,008
|
|
|
576,008
|
|
|
Outplacement Services
|
|
951,000
|
|
|
—
|
|
|
951,000
|
|
|
—
|
|
|
951,000
|
|
|
—
|
|
|
—
|
|
|
Excise Tax & Gross-Up
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,797,652
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
5,140,808
|
|
|
4,189,808
|
|
|
5,140,808
|
|
|
—
|
|
|
22,554,056
|
|
|
6,492,404
|
|
|
6,492,404
|
|
|
Richard L. Bergmark
|
|
Voluntary Termination on 12/31/2014
($) |
|
Early Retirement on 12/31/2014($)
|
|
Involuntary Not For Cause Termination on 12/31/2014($)
|
|
For Cause Termination on 12/31/2014($)
|
|
Termination related to Change-in-Control on 12/31/2014
($) |
|
Disability on 12/31/2014
($) |
|
Death on 12/31/2014
($) |
|||||||
|
Compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Severance
|
|
1,017,200
|
|
|
1,017,200
|
|
|
1,017,200
|
|
|
—
|
|
|
1,525,800
|
|
|
—
|
|
|
—
|
|
|
Short-term Incentive
|
|
686,610
|
|
|
686,610
|
|
|
686,610
|
|
|
—
|
|
|
2,190,240
|
|
|
—
|
|
|
—
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Unvested and Accelerated
Equity Award Programs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,373,345
|
|
|
2,373,345
|
|
|
2,373,345
|
|
|
Benefits & Perquisites:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Health and Welfare Benefits
|
|
625,906
|
|
|
625,906
|
|
|
625,906
|
|
|
—
|
|
|
625,906
|
|
|
625,906
|
|
|
625,906
|
|
|
Outplacement Services
|
|
508,600
|
|
|
—
|
|
|
508,600
|
|
|
—
|
|
|
508,600
|
|
|
—
|
|
|
—
|
|
|
Excise Tax & Gross-Up
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
2,838,316
|
|
|
2,329,716
|
|
|
2,838,316
|
|
|
—
|
|
|
7,223,891
|
|
|
2,999,251
|
|
|
2,999,251
|
|
|
Monty L. Davis
|
|
Voluntary Termination on 12/31/2014
($) |
|
Early Retirement on 12/31/2014($)
|
|
Involuntary Not For Cause Termination on 12/31/2014($)
|
|
For Cause Termination on 12/31/2014($)
|
|
Termination related to Change-in-Control on 12/31/2014
($) |
|
Disability on 12/31/2014
($) |
|
Death on 12/31/2014
($) |
|||||||
|
Compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Severance
|
|
1,017,200
|
|
|
1,017,200
|
|
|
1,017,200
|
|
|
—
|
|
|
1,525,800
|
|
|
—
|
|
|
—
|
|
|
Short-term Incentive
|
|
686,610
|
|
|
686,610
|
|
|
686,610
|
|
|
—
|
|
|
2,190,240
|
|
|
—
|
|
|
—
|
|
|
Long-term Incentives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Unvested and Accelerated
Equity Award Programs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,373,345
|
|
|
2,373,345
|
|
|
2,373,345
|
|
|
Benefits & Perquisites:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Health and Welfare Benefits
|
|
542,629
|
|
|
542,629
|
|
|
542,629
|
|
|
—
|
|
|
542,629
|
|
|
542,629
|
|
|
542,629
|
|
|
Outplacement Services
|
|
508,600
|
|
|
—
|
|
|
508,600
|
|
|
—
|
|
|
508,600
|
|
|
—
|
|
|
—
|
|
|
Excise Tax & Gross-Up
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,032,575
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
2,755,039
|
|
|
2,246,439
|
|
|
2,755,039
|
|
|
—
|
|
|
10,173,189
|
|
|
2,915,974
|
|
|
2,915,974
|
|
|
•
|
reviewed and discussed the Company's disclosure set forth herein below the heading "Compensation Discussion and Analysis" with management; and
|
|
•
|
based on the reviews and discussions referred to above, recommended to the Supervisory Board that the disclosure set forth herein below the heading "Compensation Discussion and Analysis" be included in this proxy statement and incorporated by reference into our annual report on Form 10-K for the year ended December 31,
2014
.
|
|
•
|
reviewed and discussed the Company's audited financial statements as of and for the year ended December 31,
2014
with management and with the independent registered public accountants;
|
|
•
|
considered the adequacy of the Company's internal controls and the quality of its financial reporting, and discussed these matters with management, with the internal auditors and with the independent registered public accountants;
|
|
•
|
reviewed and discussed with the independent registered public accountants (1) their judgments as to the quality of the Company's accounting policies, (2) the written disclosures and the letter from the independent registered public accountants required by Public Company Accounting Oversight Board Independence Rules, and the independent registered public accountants' independence, and (3) the matters required to be discussed by Public Company Accounting Oversight Board AU Section 380, Communication with Audit Committees by the Auditing Standards Board of the American Institute of Certified Public Accountants;
|
|
•
|
discussed with management, with the internal auditors and with the independent registered public accountants the process by which the Company's chief executive officer and chief financial officer make the certifications required by the SEC in connection with the filing with the SEC of the Company's periodic reports, including reports on Forms 10-K and 10-Q;
|
|
•
|
pre-approved all auditing services and non-audit services to be performed for the Company by the independent registered public accountants as required by the applicable rules promulgated pursuant to the Exchange Act, considered whether the rendering of non-audit services was compatible with maintaining PricewaterhouseCoopers' independence, and concluded that PricewaterhouseCoopers' independence was not compromised by the provision of such services (details regarding the fees paid to PricewaterhouseCoopers in fiscal
2014
for audit services, audit-related services, tax services and all other services, are set forth at "Audit Fee Summary" below); and
|
|
•
|
based on the reviews and discussions referred to above, recommended to the Supervisory Board that the financial statements referred to above be included in the Company's Annual Report on Form 10-K for the year ended December 31,
2014
.
|
|
|
2014
|
|
2013
|
||
|
|
($)
|
|
($)
|
||
|
Audit Fees
|
2,778,000
|
|
|
2,799,000
|
|
|
Audit-Related Fees
|
—
|
|
|
—
|
|
|
Tax Fees
|
105,000
|
|
|
111,000
|
|
|
All Other Fees
|
51,000
|
|
|
26,000
|
|
|
Total
|
2,934,000
|
|
|
2,936,000
|
|
|
Item 2.
|
Ratification of Appointment of PricewaterhouseCoopers as our Independent Registered Public Accounting Firm for
2015
|
|
Item 3.
|
To Approve, on an Advisory Basis, the Compensation of our Named Executive Officers as Described in the CD&A Section of this Proxy Statement
|
|
CORE LABORATORIES N.V.
C/O COMPUTERSHARE TRUST CO., N.A.
ATTN: JENNIFER HARLA
250 ROYALL STREET
CANTON, MA 02021
|
|
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Daylight Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
|
|
|
|
|
|
|
|
|
|
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
|
|
|
|
|
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
|
|
|
|
|
|
|
|
|
|
VOTE BY PHONE - 1-800-690-6903
|
|
|
|
|
Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Daylight Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.
|
|
|
|
|
|
|
|
|
|
VOTE BY MAIL
|
|
|
|
|
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|
M52480-P33425-P33515
|
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
|
||||
|
|
DETACH AND RETURN THIS PORTION ONLY
|
|||
|
CORE LABORATORIES N.V.
|
|
|
|
|
|
|
The Board of Supervisory Directors recommends that you vote FOR the following:
|
|
For
|
Withhold
|
|
|
|
1. To re-elect two Class III Supervisory Directors to serve until our annual meeting in 2018 and until their successors shall have been duly elected and qualified;
|
|
|
|
|
|
|
1a) Richard L. Bergmark
|
|
c
|
c
|
|
|
|
1b) Margaret Ann van Kempen
|
|
c
|
c
|
|
|
|
|
|
For
|
Against
|
Abstain
|
|
|
|
For
|
Against
|
Abstain
|
|
The Board of Supervisory Directors recommends you vote FOR the following proposals:
|
|
|
|
|
|
|
|
|
|
|
|
2. To ratify the appointment of PricewaterhouseCoopers as our Company's independent registered public accountants for the year ending December 31, 2015.
|
|
c
|
c
|
c
|
|
7. To approve and resolve the extension of the authority to issue shares and/or to grant rights (including options to purchase) with respect to our common and preference shares up to a maximum of 10% of outstanding shares per annum until November 21, 2016.
|
|
c
|
c
|
c
|
|
3. To approve, on an advisory basis, the compensation, philosophy, policies and procedures described in the CD&A, and the compensation of Core Laboratories N.V.'s named executive officers as disclosed pursuant to the SEC's compensation disclosure rules, including the compensation tables.
|
|
c
|
c
|
c
|
|
8. To approve and resolve the extension of the authority to limit or exclude the preemptive rights of the holders of our common shares and/or preference shares up to a maximum of 10% of outstanding shares per annum until November 21, 2016.
|
|
c
|
c
|
c
|
|
4. To confirm and adopt our Dutch Statutory Annual Accounts in the English language for the fiscal year ended December 31, 2014.
|
|
c
|
c
|
c
|
|
9. To approve the appointment of KPMG as our Company's independent registered public accountants for the year ending December 31, 2016.
|
|
c
|
c
|
c
|
|
5. To approve and resolve the cancellation of our repurchased shares held at 12:01 a.m. CEST on May 21, 2015.
|
|
c
|
c
|
c
|
|
|
|
|
|
|
|
6. To approve and resolve the extension of the existing authority to repurchase up to 10% of our issued share capital from time to time for an 18-month period, until November 21, 2016, and such repurchased shares may be used for any legal purpose.
|
|
c
|
c
|
c
|
|
NOTE: Such other business as may properly come before the annual meeting or any adjournment thereof shall be voted in accordance with the discretion of the attorneys and proxies appointed hereby.
|
|
|
|
|
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.
|
||||
|
|
|
|
|
|
|
Signature (PLEASE SIGN WITHIN BOX)
|
Date
|
|
Signature (Joint Owners)
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
CORE LABORATORIES N.V.
|
|
|
||
|
|
|
Annual Meeting of Shareholders
|
|
|
||
|
|
|
May 21, 2015 2:30 PM CEST
|
|
|
||
|
|
|
This proxy is solicited by the Board of Supervisory Directors
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
This Proxy is being solicited on behalf of the Board of Supervisory Directors of Core Laboratories N.V. for the Annual Meeting of Shareholders to be held on Thursday, May 21, 2015.
|
|
|
||
|
|
|
|
|
|
|
|
|
|
The undersigned hereby constitutes and appoints each member of the Supervisory Board, Mark Elvig, general counsel of the Company, Jacobus Schouten, as well as Jaap Stoop, and any other lawyer or Notary working with NautaDutilh N.V., the Company's Dutch legal counsel, and each or either of them, his true and lawful attorneys and proxies with full power of substitution, for and in the name, place and stead of the undersigned, to attend the Annual Meeting of Shareholders of Core Laboratories N.V. to be held at the Hotel Sofitel Legend the Grand Amsterdam, Oudezijds Voorburgwal 197, 1012 EX Amsterdam The Netherlands, on Thursday, May 21, 2015 at 2:30 p.m. CEST and any adjournment(s) thereof, with all powers the undersigned would possess if personally present and to vote thereof, as provided on the reverse side of this card, the number of shares the undersigned would be entitled to vote if personally present. In accordance with their discretion, said attorneys and proxies are authorized to vote upon such other matters and issues as may properly come before the meeting or any adjournment thereof.
|
|
||||
|
|
|
|
|
|
|
|
|
|
THIS PROXY IS BEING SOLICITED ON BEHALF OF THE BOARD OF SUPERVISORY DIRECTORS. THIS PROXY WILL BE VOTED AS DIRECTED. IN THE ABSENCE OF DIRECTION, THIS PROXY WILL BE VOTED FOR THE TWO NOMINEES FOR SUPERVISORY DIRECTOR AND FOR PROPOSALS 2, 3, 4, 5, 6, 7, 8, AND 9.
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address Changes/Comments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side)
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
Continued and to be signed on reverse side
|
|
|
||
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|